Close



Apr 18, 2024 04:05PM
Mar 20, 2024 08:01AM
Mar 20, 2024 08:00AM
Mar 7, 2024 04:01PM
Nov 7, 2023 04:35PM
Nov 7, 2023 04:09PM
Nov 7, 2023 04:01PM Lumos Pharma Announces Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in PGHD Met All Primary and Secondary Endpoints
Jul 26, 2023 09:00AM
Jul 12, 2023 08:00AM
Jun 28, 2023 04:01PM
Jun 28, 2023 04:01PM
Jun 28, 2023 04:01PM
Jun 21, 2023 09:00AM
May 31, 2023 08:00AM Lumos Pharma to Participate in the Upcoming 2023 BIO International Convention and the Jefferies Healthcare Conference
May 25, 2023 08:00AM
May 22, 2023 09:00AM
May 8, 2023 08:00AM
May 3, 2023 04:05PM
Apr 27, 2023 09:00AM
Apr 27, 2023 09:00AM
Apr 19, 2023 09:00AM Lumos Pharma to Report First Quarter 2023 Financial Results and Host Conference Call on May 3, 2023
Apr 19, 2023 09:00AM
Mar 9, 2023 04:05PM
Mar 9, 2023 04:05PM
Mar 5, 2023 02:00PM
Mar 5, 2023 02:00PM
Mar 1, 2023 04:05PM
Mar 1, 2023 04:05PM Lumos Pharma Reports Full Year 2022 Financial Results, Provides Clinical Development Updates
Feb 28, 2023 04:05PM
Feb 28, 2023 04:05PM
Feb 15, 2023 04:05PM
Feb 15, 2023 04:05PM
Jan 3, 2023 09:00AM
Jan 3, 2023 09:00AM
Dec 12, 2022 07:31AM Lumos Pharma, Inc. (LUMO) Announces KOL Review of Interim Phase 2 Data Supports Potential for New Oral Therapeutic Paradigm for Moderate Idiopathic PGHD Patients
Dec 12, 2022 07:30AM
Dec 12, 2022 07:30AM
Nov 29, 2022 04:05PM
Nov 29, 2022 04:05PM
Nov 22, 2022 04:05PM
Nov 22, 2022 04:05PM
Nov 14, 2022 06:10AM Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
Nov 14, 2022 06:10AM
Nov 14, 2022 06:02AM
Nov 14, 2022 06:00AM
Nov 14, 2022 06:00AM
Sep 26, 2022 04:05PM
Sep 26, 2022 04:05PM
Aug 31, 2022 09:00AM Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Aug 31, 2022 09:00AM

251,761 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All